CYNTHIA PAPENDICK: Open Payments
NPI 1366423899 · UNION PIER, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$369 in 13 payments from 6 companies in 2025. Trend: 2023 $279 · 2024 $316 · 2025 $369
Food & beverage: $369
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $155 |
| Neurocrine BioSciences, Inc. | 4 | $140 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: CAPLYTA, INGREZZA, PENMENVY, Auvelity, TRINTELLIX, REXULTI.
Industry payments across MI — which companies pay providers there.
